Using a model of pain hypersensitivity in bone cancer–bearing rats, the authors show that intrathecal injection of calcineurin enhances TRESK mRNA and protein expression, as well as TRESK-mediated current [41]. The gene discussed is KCNK18; the disease is bone neoplasm.